EP Patent

EP0253104A1 — Controlled release bases for pharmaceuticals

Assigned to Mundipharma CVA · Expires 1988-01-20 · 38y expired

What this patent protects

The release of therapeutically active agents from controlled release bases is extended by using a combination of a higher aliphatic alcohol and an acrylic resin as the base material.

USPTO Abstract

The release of therapeutically active agents from controlled release bases is extended by using a combination of a higher aliphatic alcohol and an acrylic resin as the base material.

Drugs covered by this patent

Patent Metadata

Patent number
EP0253104A1
Jurisdiction
EP
Classification
—
Expires
1988-01-20
Drug substance claim
No
Drug product claim
No
Assignee
Mundipharma CVA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.